Anthropic has introduced a range of new features for its Claude artificial intelligence platform, expanding its focus on the healthcare and life sciences sectors. These developments include tools for individual users to manage personal health information, as well as enterprise solutions for healthcare providers, insurers, and life science organizations. The initiative coincides with the JPMorgan Healthcare Conference and follows similar announcements from other AI companies.
Consumer Healthcare Offerings
For individual users, Anthropic's Claude Pro and Max subscribers in the U.S. can now integrate various personal health records. This includes direct connections for electronic medical records from over 50,000 health systems through a partnership with HealthEx. Users can connect these records to Claude to pose questions about lab results, doctor discussions, or health changes, with the AI's responses informed by their personal health history.
Additionally, integrations with Apple Health and Android Health Connect are being rolled out, with some scheduled for beta release. Connectors for Function Health, a platform designed for scheduling lab tests and interpreting results, are also available. These features aim to assist users in understanding medical information and navigating health-related inquiries.
Enterprise Solutions for Healthcare Providers and Insurers
Anthropic is also targeting enterprise customers, including hospitals and insurance companies, with new offerings designed to streamline administrative and clinical workflows. These features are built on a HIPAA-ready infrastructure and include connections to several industry-standard databases, such as:
- The Centers for Medicare & Medicaid Services Coverage Database
- International Classification of Diseases (ICD-10)
- National Provider Identifier Registry
- PubMed
These tools are intended to assist with tasks such as preparing prior authorization requests for specialist care, supporting insurance appeals by aligning clinical guidelines with patient records, managing claims appeals, coordinating care, and triaging patient messages.
Life Sciences Expansion and Research Support
The platform's life sciences offerings have been expanded beyond preclinical research to support clinical trial operations and regulatory work. New connectors are available for:
- Medidata (for clinical trial data)
- ClinicalTrials.gov
- bioRxiv and medRxiv (research paper repositories)
- Open Targets (a drug targets database)
- ChEMBL (a database for bioactive compounds)
Anthropic is collaborating with several healthcare and pharmaceutical organizations, including AstraZeneca, Sanofi, Genmab, Banner Health, Flatiron Health, and Veeva. One demonstrated application includes reducing the time required to draft a Phase II clinical trial protocol for Parkinson’s Disease from several days to approximately one hour.
Data Privacy and Professional Oversight
Anthropic emphasizes privacy protections for health data. Information shared with Claude is excluded from the model's memory and is not used for training future AI systems. Users retain control over their data, including the ability to disconnect or modify permissions at any time. The Model Context Protocol (MCP) is utilized by HealthEx and Claude to securely retrieve relevant portions of a user's record for specific questions, requiring user consent.
AI companies, including Anthropic and others in the sector, caution that their systems are not substitutes for professional medical judgment and have the potential to make errors. Anthropic's acceptable use policy mandates that a qualified professional must review any content or decisions generated by Claude before finalization in critical healthcare contexts.
Technological Underpinnings
These new capabilities are attributed to recent advancements in Anthropic's AI models, specifically Claude Opus 4.5. This iteration reportedly demonstrates enhanced performance on medical and scientific tasks, alongside progress in reducing factual inaccuracies during internal honesty evaluations. The company’s expansion into healthcare aligns with a broader industry trend, with other major AI companies also introducing health-focused features.